![](https://acino.swiss/wp-content/themes/acino/dist/ims/placeholders/placeholder-news-archive.png)
15.02.2017
Appointment of Mario Ricard as COO and member of the Executive Committee
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
Acino announces the appointment of Mario Ricard as Chief Operations Officer and member of the Executive Committee effective February 15,...
Barthold Piening, Chief Operations Officer and Member of the Executive Committee, has decided to leave Acino by mid of this...
On November 30, 2016, Acino International AG and Acino Pharma AG (together “Acino”) closed the deal with Luye Pharma Group...
Following the announcement of Acino and Takeda that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia, the closing of...
Acino is very pleased to launch today its new corporate brand identity and its new website under the URL www.acino.swiss.The new...
Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd....
Acino and Takeda announced today that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia.The packaging site in Estonia is...
Acino today announced that it has completed the acquisition of the MENA operations and product rights for MOVICOL®, MOVIPREP®, KLEAN-PREP® and...
Effective October 1, 2015, Acino Pharma, an international pharmaceutical company headquartered in Switzerland, acquires Pharma Start, the 9th largest local...